ApoE genotype and protease-inhibitor-associated hyperlipidaemia

被引：34

作者：

Behrens, G ^{[1
]}

Schmidt, HHJ

Stoll, M

Schmidt, RE

机构：

[1] Hannover Med Sch, Dept Clin Immunol, D-306 Hannover, Germany

[2] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany

来源：

LANCET | 1999年 / 354卷 / 9172期

关键词：

D O I：

10.1016/S0140-6736(05)75347-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：76 / 76

页数：1

相关论文

共 5 条

[1] Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors
Behrens, G
Dejam, A
Schmidt, H
Balks, HJ
Brabant, G
Körner, T
Stoll, M
Schmidt, RE
[J]. AIDS, 1999, 13 (10) : F63 - F70
[2] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
Carr, A
Samaras, K
Burton, S
Law, M
Freund, J
Chisholm, DJ
Cooper, DA
[J]. AIDS, 1998, 12 (07) : F51 - F58
[3] HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy
Corder, EH
Robertson, K
Lannfelt, L
Bogdanovic, N
Eggertsen, G
Wilkins, J
Hall, C
[J]. NATURE MEDICINE, 1998, 4 (10) : 1182 - 1184
[4] Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors
Lister, RK
Youle, M
Nair, DR
Winder, AF
Rustin, MHA
[J]. LANCET, 1999, 353 (9165) : 1678 - 1678
[5] Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
Mamotte, CDS
Sturm, M
Foo, JI
Van Bockxmeer, FM
Taylor, RR
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (03): : E553 - E557